Literature DB >> 7128047

Glycosaminoglycans produced by human synovial cell cultures.

D Hamerman, C Smith, H D Keiser, R Craig.   

Abstract

Human synovial cells in culture are known to synthesize hyaluronic acid, but the production of sulfated glycosaminoglycans (GAG) has received less attention. Using 14C-glucosamine as a precursor, GAG content was studied in the medium, trypsin-solubilized pericellular layer, and cell residue fraction of cultured synovial cells derived from the synovial membranes of nonrheumatoid and rheumatoid joints. Over 90% of the total non-dialyzable counts appeared in the culture medium, for the most part in hyaluronic acid. The remaining nondialyzable counts were cell-associated, almost equally divided between the pericellular layer and cell residues. In these fractions, only part of the counts were in GAG susceptible to testicular hyaluronidase digestion, and GAG were significantly lower in the cell residue of the rheumatoid synovial cells compared to the nonrheumatoid cells. Analysis of the chondroitinase ABC and AC digestion products of these GAG indicated the presence of chondroitin-4 and -6 sulfates, and dermatan sulfate, but not heparan sulfate. Similar findings with respect to the identity of the GAG in nonrheumatoid and rheumatoid synovial cell culture media were obtained with 35SO4 as a precursor.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7128047     DOI: 10.1016/s0174-173x(82)80023-x

Source DB:  PubMed          Journal:  Coll Relat Res        ISSN: 0174-173X


  11 in total

Review 1.  Reconstruction of an in vitro niche for the transition from intervertebral disc development to nucleus pulposus regeneration.

Authors:  Mark Shoukry; Jingting Li; Ming Pei
Journal:  Stem Cells Dev       Date:  2013-02-15       Impact factor: 3.272

2.  Measurement of sulphated glycosaminoglycans and proteoglycan fragments in arthritic synovial fluid.

Authors:  G Carroll
Journal:  Ann Rheum Dis       Date:  1989-01       Impact factor: 19.103

3.  Distinctive fibroblastic subpopulations in skin and oral mucosa demonstrated by differences in glycosaminoglycan content.

Authors:  R E Bronson; J G Argenta; E P Siebert; C N Bertolami
Journal:  In Vitro Cell Dev Biol       Date:  1988-11

4.  Reduction of the concentration and total amount of keratan sulphate in synovial fluid from patients with osteoarthritis during treatment with piroxicam.

Authors:  G J Carroll; M C Bell; B A Laing; S McCappin; C Blumer; A Leslie
Journal:  Ann Rheum Dis       Date:  1992-07       Impact factor: 19.103

5.  Hyaluronic acid production in vitro by synovial lining cells from normal and rheumatoid joints.

Authors:  I M Dahl; G Husby
Journal:  Ann Rheum Dis       Date:  1985-10       Impact factor: 19.103

6.  Enhancing and maintaining chondrogenesis of synovial fibroblasts by cartilage extracellular matrix protein matrilins.

Authors:  M Pei; J Luo; Q Chen
Journal:  Osteoarthritis Cartilage       Date:  2008-02-20       Impact factor: 6.576

7.  The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the extracellular environment.

Authors:  M M Smith; P Ghosh
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

8.  Comparison of keratan sulphate concentrations and the size distribution of proteoglycans in the synovial fluid of patients with osteoarthritis and pyrophosphate arthropathy.

Authors:  G Carroll; S McCappin; M Bell; A Schwarzer; P Breidahl
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

9.  Engineering of functional cartilage tissue using stem cells from synovial lining: a preliminary study.

Authors:  Ming Pei; Fan He; Vincent L Kish; Gordana Vunjak-Novakovic
Journal:  Clin Orthop Relat Res       Date:  2008-05-30       Impact factor: 4.176

10.  Ganglioside GM3 Up-Regulate Chondrogenic Differentiation by Transform Growth Factor Receptors.

Authors:  Jae-Sung Ryu; Sang Young Seo; Eun-Jeong Jeong; Jong-Yeup Kim; Yong-Gon Koh; Yong Il Kim; Young-Kug Choo
Journal:  Int J Mol Sci       Date:  2020-03-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.